Albumin 5% 250mL and 500mL presentations are critically short secondary to manufacturing delays. The duration of the shortage is unknown and earliest estimates on resolution are mid-late October 2022. HonorHealth is allocated only 60% of typical use, thus conservation strategies are necessary to continue to provide therapy for patients most likely to benefit. Read the full update HERE.